NANOPARTICLE-BASED BIOMARKERS FOR EARLY DIAGNOSIS AND PROGNOSIS OF CANCER
Afghanistan Afghanistan 
Indonesia 
Article Sidebar
-
Biomarkers, Cancer Prognosis, Cancer Detection, Early Diagnosis, Nanoparticles
Abstract
Nanoparticle-based biomarkers have shown great potential for the early diagnosis and prognosis of cancer, offering enhanced sensitivity and specificity compared to traditional diagnostic methods. The use of nanoparticles as carriers for biomolecules enables the detection of low-abundance biomarkers in the bloodstream, facilitating the identification of cancer at its early stages when treatment options are more effective. This study investigates the development and application of nanoparticle-based biomarkers for improving cancer detection and prognosis. The primary objective of this research is to evaluate the diagnostic and prognostic capabilities of nanoparticle-functionalized biomarkers in detecting various types of cancer. In vitro assays, animal models, and clinical sample analysis were employed to assess the binding affinity, detection sensitivity, and prognostic value of these biomarkers. The results indicate that nanoparticle-based biomarkers significantly enhance the detection of specific cancer markers, achieving high sensitivity and specificity, particularly in detecting early-stage cancer. Additionally, these biomarkers show promise in predicting tumor progression and patient outcomes. In conclusion, nanoparticle-based biomarkers represent a promising tool for the early diagnosis and prognosis of cancer, with the potential to improve clinical decision-making and treatment outcomes by enabling timely interventions.
Full text article
References
Aksoy, Z. B., Il, D. B., Celik, D., Sengun, D. N., Unal, M. A., Kaya, S. I., Yilmazer, A., & Ozkan, S. A. (2024). Bridging the gap: Advanced biosensor technologies for early-stage oral cancer diagnosis based on biomarker detection. TrAC Trends in Analytical Chemistry, 180, 117923. https://doi.org/10.1016/j.trac.2024.117923
Ali, H., Khan, N. H., Cano, D., Cano, G., Celik, M., Lilo, S., Fabia, A., Yama, A., Gudino, E., & Beker, B. N. (2025). Non-coding RNA biomarkers in basal-like breast cancer. Clinica Chimica Acta, 576, 120408. https://doi.org/10.1016/j.cca.2025.120408
Alsafiah, C. M., Tabroni, I., Mark, E., & Maharjan, K. (n.d.). Development of Labyrinth Media to Stimulate Prosocial Behavior Skills of 5-6 years old Children in Purwakarta. Biomedical and Techno Nanomaterials, 1(1), 62–72. https://doi.org/10.55849/jsca.v1i1.453
Arman, S. A., Wang, Y., & Zou, G. (2023). Threeyasa Group Banyuwangi Company Profile Design. Biomedical and Techno Nanomaterials, 1(1), 14–24. https://doi.org/10.55849/jsca.v1i1.404
Ashwani, Bharadwaj, A., Bhamboo, N., Guguloth, M., & Gugulothu, D. (2026). Chapter 6—Carbohydrate Antigen 72-4 as biomarker in cancer diagnosis and therapeutics. In S. Talegaonkar, L. Kumar, & D. Gugulothu (Eds.), Role of Biomarkers in Cancer Diagnosis and Therapeutics (pp. 129–153). Academic Press. https://doi.org/10.1016/B978-0-443-44041-0.00025-8
Attouahri, F. Z., Laraqui, A., Chaoui, I., Tagajdid, M. R., Benbacer, L., Addoum, B., Errafii, K., Ababou, M., Attaleb, M., Ennibi, K., Ennaji, M. M., & El Mzibri, M. (2026). Chapter 43—The biomarkers landscape in lung cancer: Implication for diagnosis, prediction, and prognosis. In M. M. Ennaji (Ed.), Cancer Biomarkers and Oncoviruses (pp. 571–651). Academic Press. https://doi.org/10.1016/B978-0-443-30225-1.00036-1
Aydemir, M., Kömür, A. ?., Gündüz, E. S., Karaman, C., & Karaman, O. (2025). Breaking the Silence: AI-Enhanced Multi-Omics biosensors for liquid Biopsy-Based early diagnosis of pancreatic cancer. Microchemical Journal, 215, 114118. https://doi.org/10.1016/j.microc.2025.114118
Banerjee, S., Sharma, V., & Das Mukhopadhyay, C. (2024). Exploring emerging concepts of exosomes for the diagnosis, prognosis, and therapeutics of brain cancers. Extracellular Vesicle, 3, 100038. https://doi.org/10.1016/j.vesic.2024.100038
Chen, B., Qiu, X., & Li, Y. (2025). Recent advances in Surface-Enhanced Raman Scattering (SERS) for the diagnosis, treatment, and prognosis of ovarian cancer. Microchemical Journal, 209, 112787. https://doi.org/10.1016/j.microc.2025.112787
Choudhary, N., Kumar, D., Jyoti, T. P., Islam, M. M., Kondaveeti, S. B., Faiyazuddin, M., & Webster, T. J. (2026). Alcohol-induced extracellular vesicle signatures: Exploring liquid biopsy biomarkers for early cancer detection and prognosis. Advances in Cancer Biology - Metastasis, 16, 100176. https://doi.org/10.1016/j.adcanc.2026.100176
Chowdhury, S., Kar, K., Chakraborty, P., Mazumder, R., & Prajapati, B. G. (2026). Nanoparticles in ocular cancer: Diagnosis and treatment. Next Nanotechnology, 9, 100369. https://doi.org/10.1016/j.nxnano.2026.100369
Coguplugil, Z. K., Akin, M., Erdogan, M. S., & Sen, F. (2025). A general survey on identification of biomarkers and integration systems into electrochemical biosensors for the early diagnosis of breast cancer. Next Research, 2(3), 100628. https://doi.org/10.1016/j.nexres.2025.100628
Dan, Y., Zhao, X., Li, J., Zhong, H., Zhang, H., Wu, J., He, J., Li, L., Song, Q., & Xu, B. (2025). Harnessing pseudogenes for lung cancer: A novel epigenetic target in diagnosis, prognosis and treatment. Critical Reviews in Oncology/Hematology, 208, 104645. https://doi.org/10.1016/j.critrevonc.2025.104645
De Giorgis, V., Barberis, E., & Manfredi, M. (2024). Extracellular vesicles proteins for early cancer diagnosis: From omics to biomarkers. Seminars in Cancer Biology, 104–105, 18–31. https://doi.org/10.1016/j.semcancer.2024.07.003
Deshmukh, R., Desai, S. A., Patel, V. P., Narote, S., & Raut, N. (2025). Advancing ovarian cancer management: Role of nucleic acid biomarkers and novel therapeutic approaches. Gene Reports, 40, 102241. https://doi.org/10.1016/j.genrep.2025.102241
Ding, L., Li, Y., Liu, T., He, X., Zhao, Y., Pan, B., Yang, W., Yang, X., Guo, W., & Wang, B. (2026). Plasma exosome-derived tsRNAs as a novel noninvasive biomarker for early detection and prognosis prediction of hepatocellular carcinoma. Genes & Diseases, 102180. https://doi.org/10.1016/j.gendis.2026.102180
El Garrab, Chaimae., & Zekriti, Mohssin. (2025). Tuning sensitivity and limit of detection of nanoparticle dimer based on SiO2@Au core-shell for breast cancer diagnosis and prediction of treatment benefit. Medical Engineering & Physics, 146, 104437. https://doi.org/10.1016/j.medengphy.2025.104437
Escaleira da Silva, M. C., Campos, V. S. de, do Val da Silva, M. P. A., & Ferrer, V. P. (2025). Liquid biopsy for the diagnosis, prognosis, and monitoring of common cancers: Global and Brazilian perspectives. Oncologie, 28(1), 3–32. https://doi.org/10.1515/oncologie-2025-0281
Filippou, P. S., & Dey, P. (2025). Proteomic Biomarkers and Diagnostic Tools in Ovarian Cancer: Understanding Their Clinical Value and Limitations. Journal of Proteome Research, 24(7), 3137–3153. https://doi.org/10.1021/acs.jproteome.5c00088
Hasanah, I. U., Tabroni, I., Brunel, B., & Alan, M. (2023). Development of Media Matching Box to stimulate symbolic thinking skills in children aged 4-5 years. Biomedical and Techno Nanomaterials, 1(1), 1–13. https://doi.org/10.55849/jsca.v1i1.442
Iovanna, J., Chelala, C., Choi, K. S., Couvreur, P., Ducreux, M., Dusetti, N., Gallinger, S., Hamamoto, R., Hammel, P., Janowska, A., Lee, B., Maitra, A., Neoptolemos, J., Nishio, M., Pantel, K., Robbins, H., Rodriguez, R., Saur, D., Urrutia, R., … Quesnel, B. (2026). Meeting Report G7 Cancer Conference Poor prognosis cancers: From resignation to revolution. Journal of Gastrointestinal Surgery Open, 100012. https://doi.org/10.1016/j.jogsop.2026.100012
Ismail, E., Ahmed, M., Elzwawy, A., Rashdan, H. R. M., Youssef, C. R., & Chetty, M. (2026). Noble Metal Nanoparticles in Oral Cancer: Advances in Diagnosis and Therapeutic Applications – A Review. Materials Chemistry and Physics, 132652. https://doi.org/10.1016/j.matchemphys.2026.132652
Jalalpure, S. S., Kurangi, B. K., & Gaonkar, S. M. N. (2026). Chapter 7—Aminopeptidase N—biomarker in cancer diagnosis and therapeutics. In S. Talegaonkar, L. Kumar, & D. Gugulothu (Eds.), Role of Biomarkers in Cancer Diagnosis and Therapeutics (pp. 155–176). Academic Press. https://doi.org/10.1016/B978-0-443-44041-0.00001-5
Jiao, J., Yin, M., Wang, Z., Hu, B., Chi, J., Lu, L., Dai, F., Xue, L., Wang, T., Wang, X., Zhao, J., Zhao, L., & Chen, Q. (2025). An oriented self-assembly biosensor with built-in error-checking for precise midkine detection in cancer diagnosis and prognosis evaluation. Biosensors and Bioelectronics, 268, 116905. https://doi.org/10.1016/j.bios.2024.116905
Kamyab, H., Khalili, E., Chelliapan, S., & Rajendran, S. (2026). Advancing cancer diagnosis and therapy: MXene-based biosensing and nanomedicine applications. International Immunopharmacology, 176, 116464. https://doi.org/10.1016/j.intimp.2026.116464
Khachornsakkul, K., Trakoolwilaiwan, T., Leelasattarathkul, T., & Alahmad, W. (2026). Ultrasensitive photothermal/fluorescent paper-based microfluidic immunosensor for nuclear matrix protein 22 quantification in human urine samples for rapid diagnosis of bladder cancer. Sensors and Actuators B: Chemical, 460, 139914. https://doi.org/10.1016/j.snb.2026.139914
Maleki, F., Rashidi, M.-R., & Vahedi, A. (2026). MXene-based composite electrochemical immunosensors for cancer biomarker detection: A comprehensive review of current advances, challenges, and future perspectives. Microchemical Journal, 221, 116926. https://doi.org/10.1016/j.microc.2026.116926
Mayoral-Peña, K., González Peña, O. I., Artzi, N., & de Donato, M. (2025). Biomarker discovery for early breast cancer diagnosis using machine learning on transcriptomic data for biosensor development. Computers in Biology and Medicine, 196, 110584. https://doi.org/10.1016/j.compbiomed.2025.110584
Qiu, T., Cai, X., Lan, L., Wu, S., Li, X., Yang, Y., Wang, W., Wang, X., Zhong, X., An, Y., & Cheng, L. (2026). Emerging paradigms of cobalt-based nanozymes in cancer control: Prevention, treatment, and prognosis. Coordination Chemistry Reviews, 564, 218075. https://doi.org/10.1016/j.ccr.2026.218075
Sarac, B., Ad?güzel, B., Yücer, S., Ozdemir Karabag, D. G., Gürbüz Sahin, B., & Ciftci, F. (2026). Nanocomposite biosensors for cancer biomarker detection: From sensing mechanisms to prognostic applications. Nano-Structures & Nano-Objects, 46, 101657. https://doi.org/10.1016/j.nanoso.2026.101657
Shukla, M., Patel, J. C., Shukla, M., & Das Purkayastha, K. (2026). Biomarkers for cancer screening, diagnosis and targeted therapeutic approaches. In Advances in Cancer Research. Academic Press. https://doi.org/10.1016/bs.acr.2025.12.008
Silva, F. S., Sousa, C., & Mendes, A. F. (2026). Long non-coding RNAs: New perspectives for the diagnosis, prognosis, and treatment of pancreatic cancer. Biochemical Pharmacology, 250, 117933. https://doi.org/10.1016/j.bcp.2026.117933
Sohal, P., & Guleria, R. (2026). Role of biomarkers in cancer detection, diagnosis, and treatment. In Advances in Cancer Research. Academic Press. https://doi.org/10.1016/bs.acr.2025.12.004
Soltani, A., Hosseini, S. A., & Haddadi, M. H. (2026). Metal-based biosensors for early detection of cancer biomarkers: A review of methods, challenges, and future trends. Microchemical Journal, 226, 118049. https://doi.org/10.1016/j.microc.2026.118049
Wang, W., Su, Y., Zhang, W., Xu, B., & Hu, T. (2026). Electrochemical sensor monitoring biomarker molecular structure and clinical diagnosis of prostate cancer: Risk association of neutrophil albumin ratio. Microchemical Journal, 222, 117132. https://doi.org/10.1016/j.microc.2026.117132
Authors
Copyright (c) 2026 Omar Khan, Amir Raza, Dito Anurogo
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
